VELOCITY FUND PARTNERS, LP - 20 May 2025 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

Reporting relationship: 10%+ Owner
Issuer ticker: MDCX
Reported as of: 20 May 2025
Net transaction value: -$578,940
SEC form: 4
Accepted by SEC: 21 May 2025, 12:57:08 UTC
Prior SEC filing: 21 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP

Filing notes and source

Key filing fact

VELOCITY FUND PARTNERS, LP filed Form 4 for Medicus Pharma Ltd. (MDCX) on 21 May 2025.

Key facts

This page summarizes VELOCITY FUND PARTNERS, LP's Form 4 filing for Medicus Pharma Ltd. (MDCX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 May 2025, 12:57.

Change

Previous filing in this sequence was filed on 21 May 2025.
Current net transaction value: -$578,940.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001671948 Primary reporting owner

VELOCITY FUND PARTNERS, LP

Relationship: 10%+ Owner
Address: 1100 STONEGATE MANOR, CHESWICK
Signature: /s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP
Signature date: 21 May 2025

CIK 0002050471

Melani Kenneth R.

Relationship: 10%+ Owner
Address: 1100 STONEGATE MANOR, CHESWICK
Signature: /s/ Kenneth R. Melani
Signature date: 21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX transaction

Medicus Pharma LTD

Sale

Transaction value: -$578,940
Shares: -75,000
Change %: -2.3%
Price: $7.72
Shares after: 3,248,741
Date: 20 May 2025
Ownership: See Footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The common shares were sold by Velocity Fund Partners, LP pursuant to an open market sale of 75,000 common shares on May 20, 2025 at a net price per common share of $7.7192.

Footnote F2

Represents 2,839,330 common shares held by Velocity Fund Partners, LP an entity controlled by Dr. Kenneth R. Melani and 409,411 common shares held directly by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership of common shares held by Velocity Fund Partners, LP, except to the extent of his pecuniary interest therein.